Source:http://linkedlifedata.com/resource/pubmed/id/12451244
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-26
|
| pubmed:abstractText |
Vasogen Inc.'s (Mississauga, Ontario, Canada) immune modulation therapy (IMT) is a therapy in which cells from the patient's own blood are modified by ex vivo exposure to specific physicochemical stressors, including oxidation, ultraviolet (UV) light, and an elevated temperature. The therapy has been shown to have a beneficial effect in models of inflammation and vascular diseases. This study tested the hypothesis that IMT can prevent renal ischemia-reperfusion (I/R) injury in rats.
|
| pubmed:language |
eng
|
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author |
pubmed-author:BoltonAnthony EAE,
pubmed-author:ChenHuifangH,
pubmed-author:Der SarkissianShantS,
pubmed-author:GabouryLouisL,
pubmed-author:GouadonElodieE,
pubmed-author:HametPavelP,
pubmed-author:KunesJaroslavJ,
pubmed-author:MarshanskyVladimirV,
pubmed-author:PengJunzhengJ,
pubmed-author:TremblayJohanneJ,
pubmed-author:VuMinh DiemMD,
pubmed-author:deBloisDenisD
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1425-33
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:articleTitle |
Renal ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy.
|
| pubmed:affiliation |
Centre de recherche, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
|